Bcl9 | B cell CLL/lymphoma 9
Physiological systems
17 / 24 physiological systems tested
4 Significantly impacted by the knock-out
Embryo Growth/size/body region Behavior/neurological Mortality/aging
13 No significant impact
7 Not tested
Data collections
Gene metrics:5Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
hyperactivity | 2 supporting datasets | Bcl9em1(IMPC)Bay | heterozygote | Early adult | 4.17x10-6 | ||
abnormal locomotor behavior | 1 supporting dataset | Bcl9em1(IMPC)Bay | heterozygote | Early adult | 8.23x10-7 | ||
preweaning lethality, incomplete penetrance | 2 supporting datasets | Bcl9em1(IMPC)Bay | homozygote | Early adult | N/A * | ||
abnormal embryo size | 1 supporting dataset | Bcl9em1(IMPC)Bay | heterozygote | E15.5 | N/A * | ||
preweaning lethality, complete penetrance | 1 supporting dataset | Bcl9em1(IMPC)Bay | homozygote | Early adult | N/A * |
| | | | | | | | | |
External links
No external links available for Bcl9.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Bcl9em1(IMPC)Bay | Exon Deletion | | mouse |
Bcl9tm1a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
Bcl9tm1e(EUCOMM)Hmgu | Targeted, non-conditional allele | | ES Cell |